scholarly journals Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients

PLoS ONE ◽  
2011 ◽  
Vol 6 (12) ◽  
pp. e28617 ◽  
Author(s):  
Tatsuo Miyamura ◽  
Tatsuo Kanda ◽  
Shingo Nakamoto ◽  
Shuang Wu ◽  
Keiichi Fujiwara ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Treatment Outcomes ◽  
Nuclear Translocation ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Interleukin 28B

CP-066 Interleukin-28B polymophism as a predictor of response to telaprevir-based regimens in patients with hepatitis C virus genotype 1 infection

2014 ◽  
Vol 21 (Suppl 1) ◽  
pp. A27.1-A27
Author(s):  
M García-López ◽  
MP Ortega-García ◽  
M Diago ◽  
E Ortega-González ◽  
FJ López-Pérez ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Interleukin 28B

Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin

2012 ◽  
Vol 56 (1) ◽  
pp. 34-40 ◽  
Author(s):  
Chung-Feng Huang ◽  
Jee-Fu Huang ◽  
Jeng-Fu Yang ◽  
Ming-Yen Hsieh ◽  
Zu-Yau Lin ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Genetic Variants ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Interleukin 28B

scholarly journals Characterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment

2021 ◽  
Vol 10 (41) ◽  
Author(s):  
Martin S. Pedersen ◽  
Ulrik Fahnøe ◽  
Lone W. Madsen ◽  
Peer B. Christensen ◽  
Anne Øvrehus ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Treatment Failure ◽  
Treatment Outcomes ◽  
Limited Information ◽  
Genotype 1 ◽  
Genome Sequences ◽  
Virus Genotype ◽  
Before And After

Limited information is available in relation to surveillance, genotyping, genome sequences, and treatment outcomes for rare hepatitis C virus variants. Here, we have characterized a novel subtype of major hepatitis C virus genotype 1, which was deep sequenced before and after treatment failure with 4 weeks of glecaprevir and pibrentasvir.

Sign in / Sign up

Export Citation Format

Share Document